Proceedings of the Engineering and Physical Sciences Research Council Workshop—the development of functional imaging in the diagnosis, management and understanding of childhood brain tumours

Imaging plays a fundamental role in the management of children with brain tumours. A series of new techniques, commonly grouped under the heading functional imaging, promise to give information on the properties and biological characteristics of tissues thereby adding to the structural information available from current imaging. The EPSRC funded a workshop to bring together clinicians from the UK Children's Cancer Study Group and scientific experts in the field to identify clinical problems in childhood brain tumours that may be addressed by functional imaging and to develop a clinical test bed for applying, evaluating and developing this new technology. The presentations and discussion sessions from the workshop are summarised and a review of the current ‘state of the art’ for this rapidly developing area provided. A key output of the workshop was agreement on a series of hypotheses which can be tested in carefully designed clinical studies. © 2004 Wiley‐Liss, Inc.

[1]  W. J. Oakes,et al.  Comparison of serial PET and MRI scans in a pediatric patient with a brainstem glioma. , 1993, Medical and pediatric oncology.

[2]  Franklyn A. Howe,et al.  Comparison of in vivo1H MRS of human brain tumours with1H HR-MAS spectroscopy of intact biopsy samples in vitro , 1999, Magnetic Resonance Materials in Physics, Biology and Medicine.

[3]  R B Banati,et al.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.

[4]  A. Thiel,et al.  11C-methionine PET for differential diagnosis of low-grade gliomas , 1998, Neurology.

[5]  F. Shishido,et al.  Positron Emission Tomographic Evaluations in the Diagnosis and Therapy of Multifocal Glioblastoma , 1985 .

[6]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[7]  K. Lamborn,et al.  A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. , 1999, Journal of pediatric hematology/oncology.

[8]  E. Zackai,et al.  Intracranial visual pathway gliomas in children with neurofibromatosis. , 1988, Neurofibromatosis.

[9]  J. Smirniotopoulos,et al.  Pineal Parenchymal Tumors: CT and MR Features , 1995, Journal of computer assisted tomography.

[10]  E C Halperin,et al.  Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations. , 1989, International journal of radiation oncology, biology, physics.

[11]  Audrey E. Evans,et al.  The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial , 1989, Journal of Neuro-Oncology.

[12]  M. Leach,et al.  Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques , 2001, British Journal of Cancer.

[13]  Positron emission tomography-guided stereotactic brain biopsy. , 1992 .

[14]  M. Leach,et al.  Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells , 2001, British Journal of Cancer.

[15]  M. Leach,et al.  Potential role of magnetic resonance spectroscopy in assessment of tumour response in childhood cancer. , 2003, European journal of cancer.

[16]  T. Hölzer,et al.  The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using f-18-fluorodeoxyglucose and c-11-L-methylmethionine. , 1997, Neurosurgery.

[17]  C. Gondry-Jouet,et al.  Differential MRI diagnosis between brain abscesses and necrotic or cystic brain tumors using the apparent diffusion coefficient and normalized diffusion-weighted images. , 2003, Magnetic resonance imaging.

[18]  S. Williams,et al.  Cell type-specific fingerprinting of meningioma and meningeal cells by proton nuclear magnetic resonance spectroscopy. , 1995, Cancer research.

[19]  K Wienhard,et al.  Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  F. Berthold,et al.  In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment , 1993, Cancer.

[21]  K. Bergström,et al.  MULTIPLANAR SPINAL ANATOMY: COMPARISON OF COMPUTED TOMOGRAPHY AND CRYOMICROTOMY IN POSTMORTEM SPECIMENS , 1983 .

[22]  C. Presant,et al.  Association of intratumoral pharmacokinetics of fluorouracil with clinical response , 1994, The Lancet.

[23]  K. Brindle Metabolomics: Pandora's Box or Aladdin's Cave? , 2003 .

[24]  P. Courtheoux,et al.  The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine. , 1997, Neurosurgery.

[25]  L. J. Rubinstein,et al.  Tumours of the central nervous system , 1979, Oxford Desk Reference: Oncology.

[26]  Pek-Lan Khong,et al.  Diffusion-tensor imaging for the detection and quantification of treatment-induced white matter injury in children with medulloblastoma: a pilot study. , 2003, AJNR. American journal of neuroradiology.

[27]  A R Tate,et al.  Towards a method for automated classification of 1H MRS spectra from brain tumours , 1998, NMR in biomedicine.

[28]  D. Thomas,et al.  Pretreatment prediction of the chemotherapeutic response of human glioma cell cultures using nuclear magnetic resonance spectroscopy and artificial neural networks. , 1997, Cancer research.

[29]  J. Lindon,et al.  Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.

[30]  A. Paller Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study , 1995 .

[31]  G. Perilongo,et al.  Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. , 1998, Medical and pediatric oncology.

[32]  A. Luxen,et al.  Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy , 1995, Acta Neurochirurgica.

[33]  J Hildebrand,et al.  Positron emission tomography-guided stereotactic brain biopsy. , 1992, Neurosurgery.

[34]  P. Robinson,et al.  MEASUREMENT OF BLOOD‐BRAIN BARRIER PERMEABILITY , 1990, Clinical and experimental pharmacology & physiology.

[35]  L. Rorke,et al.  Prognostic factors in childhood ependymomas. , 1990, Pediatric neurosurgery.

[36]  P. Basser,et al.  In vivo fiber tractography using DT‐MRI data , 2000, Magnetic resonance in medicine.

[37]  D. R. Wilkie,et al.  31P-NMR STUDIES OF A HUMAN TUMOUR IN SITU , 1983, The Lancet.

[38]  S. Osman,et al.  Metabolic activation of temozolomide measured in vivo using positron emission tomography. , 2003, Cancer research.

[39]  D. Ellison,et al.  Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. , 2002, The American journal of pathology.

[40]  A. Luxen,et al.  Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. , 1995, Journal of neurosurgery.

[41]  J L Ackerman,et al.  Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic‐angle spinning , 1996, Magnetic resonance in medicine.

[42]  M. Muti,et al.  Study on the variations of the apparent diffusion coefficient in areas of solid tumor in high grade gliomas. , 2002, Magnetic resonance imaging.

[43]  R. Gupta,et al.  Variation of post-treatment H-MRSI choline intensity in pediatric gliomas. , 1999, Journal of neuro-oncology.

[44]  C. Degueldre,et al.  Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[45]  M. Leach,et al.  Initial measurements of ifosfamide and cyclophosphamide in patients using 31P MRS: Pulse‐and‐acquire, decoupling, and polarization transfer , 2000, Magnetic resonance in medicine.

[46]  Sinisa Pajevic,et al.  Color schemes to represent the orientation of anisotropic tissues from diffusion tensor data: Application to white matter fiber tract mapping in the human brain , 1999, Magnetic resonance in medicine.

[47]  A. Kirton,et al.  Evaluation of pediatric CNS malignancies with (99m)Tc-methoxyisobutylisonitrile SPECT. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[48]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[49]  D. Collins,et al.  Measurement of plasma 5-fluorouracil by high-performance liquid chromatography with comparison of results to tissue drug levels observed using in vivo 19F magnetic resonance spectroscopy in patients on a protracted venous infusion with or without interferon-alpha. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[50]  G. Reifenberger,et al.  Multimodal target point assessment for stereotactic biopsy in children with diffuse bithalamic astrocytomas , 2002, Child’s Nervous System.

[51]  W. J. Oakes,et al.  FDG-PET in pediatric posterior fossa brain tumors. , 1992, Journal of computer assisted tomography.

[52]  Reiman,et al.  Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors. , 2000, Journal of neurosurgery.

[53]  C. Meyer,et al.  Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. , 2002, Molecular imaging.

[54]  J D Pickard,et al.  Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion? , 2003, Clinical radiology.

[55]  Emanuel Petricoin,et al.  Molecular profiling of human cancer , 2000, Nature Reviews Genetics.

[56]  An Adiabatic Approximation to the Tissue Homogeneity Model for Water Exchange in the Brain : I . Theoretical Derivation , .

[57]  Mark Noble,et al.  Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours , 1995, NMR in biomedicine.

[58]  Susan M. Chang,et al.  Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors. , 2001, Magnetic resonance imaging.

[59]  R B Banati,et al.  PK (‘peripheral benzodiazepine’) – binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK 11195 binding to activated microglia , 1997, Journal of neurocytology.

[60]  K. Någren,et al.  Metabolic characterization of childhood brain tumors , 2002, Cancer.

[61]  Roger N Gunn,et al.  In-vivo measurement of activated microglia in dementia , 2001, The Lancet.

[62]  A Brun,et al.  Tumours of the Central Nervous System , 1986, Acta radiologica: diagnosis.

[63]  Ting-Yim Lee,et al.  An Adiabatic Approximation to the Tissue Homogeneity Model for Water Exchange in the Brain: I. Theoretical Derivation , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[64]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[65]  J. Charrow,et al.  Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. , 1994, The Journal of pediatrics.

[66]  Douglas B. Kell,et al.  Metabolomics and Machine Learning: Explanatory Analysis of Complex Metabolome Data Using Genetic Programming to Produce Simple, Robust Rules , 2004, Molecular Biology Reports.

[67]  S. Goldman,et al.  Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[68]  P. Kleihues,et al.  Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. , 1988, Journal of neurosurgery.

[69]  V. Sturm,et al.  11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds. , 1997, Stereotactic and functional neurosurgery.

[70]  J. Alger,et al.  Variation of Post-treatment H-MRSI Choline Signal Intensity in Pediatric Gliomas , 1999, Journal of Neuro-Oncology.

[71]  Paul Van Houtte,et al.  Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the Leksell gamma knife: early experience with brain tumors , 2009 .

[72]  R. Zimmerman,et al.  Prognostic value of proton MR spectroscopy of cerebral hemisphere tumors in children , 1998, Neuroradiology.

[73]  W. Negendank,et al.  Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.

[74]  T Metens,et al.  Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the gamma knife: early experience with brain tumors. Technical note. , 2000, Journal of neurosurgery.

[75]  O. Schober,et al.  Monitoring tumor activity in low grade glioma of childhood , 1998, Klinische Padiatrie.

[76]  S. Williams,et al.  Immortalization and transformation are associated with specific alterations in choline metabolism. , 1996, Cancer research.

[77]  Bradford A. Moffat,et al.  Diffusion MRI: A New Strategy for Assessment of Cancer Therapeutic Efficacy , 2002, Molecular imaging.

[78]  S. Goldman,et al.  Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18]fluorodeoxyglucose and [C-11]methionine. , 1997, Acta neurochirurgica. Supplement.

[79]  J. R. Griffiths Clinical applications of MR spectroscopy , 1999 .

[80]  D. Arnold,et al.  Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors , 1998, NMR in biomedicine.

[81]  Leo L. Cheng,et al.  Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy. , 2000, Neuro-oncology.

[82]  T Greitz,et al.  Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine. , 1983, Journal of computer assisted tomography.

[83]  R. K. Jain,et al.  Vessels of death or life. , 2001, Scientific American.

[84]  D. Louis Collins,et al.  Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.

[85]  C. Spenger,et al.  Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (1H MRS) , 2003, British Journal of Cancer.

[86]  T. Poggio,et al.  Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.

[87]  L. Drubach,et al.  Applications of Nuclear Medicine in Pediatric Oncology , 2002, Clinical nuclear medicine.

[88]  S. Osman,et al.  Assessment of proliferation in vivo using 2-[(11)C]thymidine positron emission tomography in advanced intra-abdominal malignancies. , 2002, Cancer research.

[89]  F Ståhlberg,et al.  Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. , 2000, AJNR. American journal of neuroradiology.

[90]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .

[91]  S. Bertolone,et al.  Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[92]  P. Tofts,et al.  Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.